ZURICH (Reuters) – Novartis AG’s cancer drug Tasigna was effective and helped achieve rapid responses as an initial therapy in newly diagnosed patients with a life threatening form of leukemia, the company said. Data from two mid-stage clinical Read More
LOS ANGELES, Dec 8 (Reuters) – An early look at data from [...]